홈 › 유방암 › 텍사스

텍사스의 유방암 임상 시험

유방암 관련 연구 176개가 텍사스 내 여러 지역에서 참여자를 모집하고 있습니다.

텍사스의 도시

공식 연구 텍스트(영어)

Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

NEXT Houston, Galveston
NEXT Oncology - PARENT, San Antonio

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT07360314

Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

Baylor College of Medicine, Houston
MD Anderson Cancer Center, Houston
Harris Health System - Smith Clinic, Houston

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT05696626

A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer

Renovatio Clinical - El Paso, El Paso
JPS Health Network, Fort Worth
Renovatio Clinical, The Woodlands

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 13. 업데이트됨 · NCT05894239

A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer

Oncology Consultants PA, Houston

피험자 모집 중1상

18세 ~ 55세 · 여성 · 2026. 11. 12. 업데이트됨 · NCT07310420

Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.

M D Anderson Cancer Center, Houston

피험자 모집 중

18세 이상 · 여성 · 2026. 11. 12. 업데이트됨 · NCT05649072

Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)

Texas Oncology - DFW ( Site 8000), Dallas
Houston Methodist Hospital ( Site 0022), Houston

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06797635

Multi-center MRD Registry for Inflammatory Breast Cancer

MD Anderson Cancer Center, Houston

피험자 모집 중관찰 연구

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06966050

An Investigational Study of BG-75202 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors

Next Oncology Austin, Austin
The University of Texas Md Anderson Cancer Center, Houston

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT07222267

BostonGene and Exigent Genomic INsight Study

Oncology Consultants, Houston

피험자 모집 중관찰 연구

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06272864

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

UT Southwestern/Simmons Cancer Center-Dallas, Dallas
UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
UT Southwestern Clinical Center at Richardson/Plano, Richardson

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT03418961

Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors

UT MD Anderson Cancer Center, Houston

피험자 모집 중1상

12세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT05372640

Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.

Research Facility, Dallas
Research Facility, Houston

피험자 모집 중1/2상

전 연령 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06590857

Safety and Feasibility of Robotic SP Nipple Sparing Mastectomy

UT Southwestern, Dallas

피험자 모집 중

18세 ~ 80세 · 여성 · 2026. 11. 12. 업데이트됨 · NCT05245812

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

Baylor Scott & White Research Institute -Texas Oncology, Dallas
UT Southwestern Medical Center, Dallas
South Texas Accelerated Research Therapeutics (START), LLC, San Antonio

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT06827236

Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma

M D Anderson Cancer Center, Houston

피험자 모집 중

18세 이상 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT03941756

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Texas Oncology - DFW ( Site 8009), Dallas
UT Southwestern ( Site 0092), Dallas
Texas Oncology - Northeast Texas ( Site 8002), Flower Mound
외 6개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT06966700

Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

The University of Texas MD Anderson Cancer Center, Houston
The University of Texas, MD Anderson Cancer Center - West Houston, Houston

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT04557449

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

University of Texas Southwestern Medical Center, Dallas
Houston Methodist Cancer Center, Houston
The University of Texas M.D. Anderson Cancer Center, Houston

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 9. 업데이트됨 · NCT07007559

Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort

UT Southwestern Medical Center, Dallas

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT05693766

Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)

MD Anderson Cancer Center, Houston

피험자 모집 중관찰 연구

18세 이상 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT05964504

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

University of Texas Southwestern Medical Center, Dallas
MD Anderson Cancer Center, Houston
South Texas Accelerated Research Therapeutics (START) San Antonio, San Antonio

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT07029399

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

The Methodist Hospital Research Institute, Houston
The University of Texas MD Anderson Cancer Center, Houston

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT06324357

A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors

The University of Texas MD Anderson Cancer Center - Conroe, Conroe
The University of Texas - M.D. Anderson Cancer Center, Houston
The University of Texas, MD Anderson Cancer Center - West Houston, Houston
외 3개

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT07318805

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Houston Methodist Hospital, Houston
Oncology Consultants, Houston

피험자 모집 중

18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT07214532

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

Texas Oncology Central/South, Austin
Texas Oncology DFW, Dallas
University of Texas Southwestern Medical Center, Dallas
외 3개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT06982521

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Hendrick Medical Center, Abilene
World Research Link, Baytown
Parkland Health and Hospital System, Dallas
외 10개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07174336

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

JPS Health Network, Fort Worth
Community Clinical Trials, Spring

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06790693

E-Mindfulness Approaches for Living After Breast Cancer

The Don and Sybil Harrington Cancer Center, Amarillo

피험자 모집 중3상

18세 ~ 50세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06748222

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

University of Texas MD Anderson Cancer Center, Houston
Houston Methodist Hospital, Houston
Oncology Consultants P.A., Houston
외 1개

피험자 모집 중2상

18세 이상 · 여성 · 2026. 11. 4. 업데이트됨 · NCT07287098

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

The Don and Sybil Harrington Cancer Center, Amarillo
UT MD Anderson Cancer Center, Houston
Audie L Murphy VA Hospital, San Antonio

피험자 모집 중관찰 연구건강한 지원자 환영

40세 ~ 75세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT05334069

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

USOR Texas Oncology, Abilene
Texas Oncology - Central / South Texas, Austin
Mary Crowley Cancer Research, Dallas
외 3개

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT05579366

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

The University of Texas - MD Anderson Cancer Center, Houston

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06400472

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Texas Oncology - DFW (Sammons CC), Dallas
Baylor College of Medicine, Houston

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07213791

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

Texas Oncology - DFW (Sammons CC), Dallas
MD Anderson Cancer Center, Houston

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07114601

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06760819

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

The Don and Sybil Harrington Cancer Center, Amarillo
Houston Methodist San Jacinto Hospital, Baytown
UT MD Anderson - The Woodlands, Conroe
외 19개

피험자 모집 중3상

18세 ~ 60세 · 여성 · 2026. 11. 4. 업데이트됨 · NCT05879926

A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors

Texas Oncology - DFW, Dallas
MD Anderson Cancer Center, Houston

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06695845

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

Texas Oncology - DFW ( Site 8003), Dallas
JPS Health Network ( Site 0067), Fort Worth
Texas Oncology - Gulf Coast ( Site 8006), Houston
외 3개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT07060807

A Study of JNJ-101684362 (HLD-0117) in Patients With Metastatic Breast Cancer

South Texas Accelerated Research Therapeutics, LLC (START), San Antonio

피험자 모집 중1상

18세 이상 · 여성 · 2026. 11. 3. 업데이트됨 · NCT07524855

A Phase 1 Study of IM-1617 in Participants With Advanced Cancer

MD Anderson Cancer Center, Houston
NEXT Dallas, Irving

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 3. 업데이트됨 · NCT07578571

ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.